Nicholas Cost, MD

My interest in testicular cancer has guided my training and career development. Testicular cancer is a disease that affects boys and men of all ages. For that reason, after completing my residency in Urology and Urologic Surgery, I pursued fellowship training in both urologic oncology (cancer treatment) and pediatric urology. This allows me to provide care to children, adolescents, and adults with testicular cancer at both “adult” and “pediatric” hospitals.

I am involved with testicular cancer both as a clinician and as a researcher.  My particular areas of focus include:

• Robotic surgery for testicular cancer
• Testicular cancer in adolescents
• The Long-term effects of testicular-cancer treatment

I believe that by working in such a wonderful environment at the University of Colorado Anschutz Medical Campus, we can provide the most current therapy as well be involved in research to improve outcomes for patients with testicular cancer.

My clinical philosophy for patient care is to first listen to the patient's concerns and needs. Then, I assess the patient's condition and previous testing and labs in order to explain my evaluation and offer my recommendations. I believe it is important to make sure the patient and family understand their condition as well as possible to enable us all to make the plan of care together, as a team.

I am available to discuss your situation with you or your physician, so please feel free to contact me anytime at the e-mail address below. I look forward to the opportunity to work with you.

Nicholas Cost, MD
nicholas.cost@ucdenver.edu

Selected Publications:

1. Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI and Margulis V. Risk Stratification for Pubertal Children and Post-pubertal Adolescents with Clinical Stage I Testicular Non-Seminomatous Germ Cell Tumors. Journal of Urology, in press, accepted August 2013.
2. Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI and Margulis V. A Comparison of Pediatric, Adolescent and Adult Testicular Germ Cell Malignancy. Pediatric Blood and Cancer, e-Pub September 17, 2013.
3. Cost NG. Testicular Germ Cell Tumors: Current Concepts and Management Strategies. Minerva Urologica e Nefrologica. 2013: 65(2):133-155.
4. Cost NG, DaJusta DG, Granberg CF, Cooksey RM, Laborde CE, Wickiser JE and Gargollo PC. Robotic Assisted Laparoscopic Retroperitoneal Lymph Node Dissection in an Adolescent Population. Journal of Endourology. 2012; 26(6):635-40.
5. Cost NG, Adibi M, Lubahn JD, Romman A, Raj GV, Sagalowsky AI and Margulis V. Effect of Testicular Germ Cell Tumor Therapy on Renal Function. Urology. 2012; 80(3):641-8.
6. Cost NG, Cost CR, Geller JI and DeFoor WR. Adolescent Urologic Oncology: Current Issues and Future Directions. Urologic Oncology: Seminars and Original Investigations, e-Pub November 7, 2012.
7. Applegate KE and Cost NG. Image Gently: A Campaign to Reduce Children’s and Adolescents’ Risk for Cancer During Adulthood. Journal of Adolescent Health. 2013; 52(5 Suppl):S93-7.